Clobetasol Propionate Patent Expiration
Clobetasol Propionate is Used for treating skin diseases using a corticosteroid-containing pharmaceutical composition. It was first introduced by Fougera Pharmaceuticals Inc
Clobetasol Propionate Patents
Given below is the list of patents protecting Clobetasol Propionate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Clobetasol Propionate | US10588913 | Aqueous suspension agent containing glucocorticosteroid nanoparticles | May 09, 2036 | Eyenovia |
Clobetasol Propionate | US11376262 | Method of treating an inflammatory or infectious disease | May 09, 2036 | Eyenovia |
Impoyz | US9855334 | Topical compositions comprising a corticosteroid | Mar 11, 2035 | Primus Pharms |
Impoyz | US10064875 | Topical formulations comprising a steroid | Aug 31, 2030 | Primus Pharms |
Impoyz | US10588914 | Topical formulations comprising a steroid | Aug 31, 2030 | Primus Pharms |
Impoyz | US9956231 | Topical formulations comprising a steroid | Aug 31, 2030 | Primus Pharms |
Olux E | US8460641 | Microemulsion process and composition | Nov 05, 2028 | Norvium Bioscience |
Olux E | US8962000 | Microemulsion and sub-micron emulsion process and compositions | Aug 31, 2025 | Norvium Bioscience |
Clobex | US7700081 | Foaming compositions for hair care |
Jan 03, 2022
(Expired) | Galderma Labs |
Olux E | US6730288 | Mousse composition |
Sep 08, 2019
(Expired) | Norvium Bioscience |
Olux E | US7029659 | Mousse composition |
Sep 08, 2019
(Expired) | Norvium Bioscience |
Clobex | US7316810 | Foaming composition for washing and treating hair and/or scalp based on an active principle |
Jun 17, 2019
(Expired) | Galderma Labs |
Clobex | US8066975 | Foaming composition for washing and treating hair and/or scalp based on an active principle |
Jun 17, 2019
(Expired) | Galderma Labs |
Clobex | US8066976 | Foaming compositions for hair care |
Jun 17, 2019
(Expired) | Galderma Labs |
Clobex | US5990100 | Composition and method for treatment of psoriasis |
Mar 24, 2018
(Expired) | Galderma Labs Lp |
Clobex | US5972920 | Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders |
Feb 12, 2018
(Expired) | Galderma Labs Lp |
Clobex | US6106848 | Topically applicable O/W emulsions having high glycol content and at least one biologically active agent |
Sep 22, 2017
(Expired) | Galderma Labs Lp |
Olux | US6126920 | Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition |
Mar 01, 2016
(Expired) | Norvium Bioscience |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Clobetasol Propionate's patents.
Latest Legal Activities on Clobetasol Propionate's Patents
Given below is the list recent legal activities going on the following patents of Clobetasol Propionate.
Activity | Date | Patent Number |
---|---|---|
Payment of Maintenance Fee, 4th Year, Large Entity | 17 Mar, 2023 | US10588913 |
Patent Issue Date Used in PTA Calculation Critical | 05 Jul, 2022 | US11376262 |
Recordation of Patent Grant Mailed Critical | 05 Jul, 2022 | US11376262 |
Email Notification Critical | 16 Jun, 2022 | US11376262 |
Issue Notification Mailed Critical | 15 Jun, 2022 | US11376262 |
Application Is Considered Ready for Issue Critical | 25 May, 2022 | US11376262 |
Dispatch to FDC | 25 May, 2022 | US11376262 |
Issue Fee Payment Received Critical | 20 May, 2022 | US11376262 |
Issue Fee Payment Verified Critical | 08 May, 2022 | US11376262 |
Mail Response to 312 Amendment (PTO-271) Critical | 08 Apr, 2022 | US11376262 |
Clobetasol Propionate's Family Patents
Explore Our Curated Drug Screens
Clobetasol Propionate Generics
Several generic applications have been filed for Clobetasol Propionate. The first generic version for Clobetasol Propionate was by Cosette Pharmaceuticals Inc and was approved on Feb 16, 1994. And the latest generic version is by Taro Pharmaceutical Industries Ltd and was approved on Mar 14, 2024.
Given below is the list of companies who have filed for Clobetasol Propionate generic.
1. ACTAVIS MID ATLANTIC
Actavis Mid Atlantic Llc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | shampoo | Discontinued | TOPICAL | N/A | Jun 7, 2011 |
2. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Alembic.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | aerosol, foam | Prescription | TOPICAL | AB1 | Apr 21, 2022 |
3. AMNEAL
Amneal Pharmaceuticals Llc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Amneal.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | shampoo | Prescription | TOPICAL | AB | Jun 14, 2021 |
4. ANI PHARMS
Ani Pharmaceuticals Inc has filed for 1 generic for Clobetasol Propionate. This 0.05% version comes by the name CLOBETASOL PROPIONATE (EMOLLIENT). Given below are the details of the strengths of this generic introduced by Ani Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | cream | Discontinued | TOPICAL | N/A | Aug 22, 2001 |
5. APOTEX
Apotex Inc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Apotex.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | spray | Discontinued | TOPICAL | N/A | Apr 17, 2018 |
6. AUROBINDO PHARMA USA
Aurobindo Pharma Usa Inc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | cream | Prescription | TOPICAL | AB1 | Feb 9, 2001 |
7. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | cream | Discontinued | TOPICAL | N/A | Mar 26, 2021 |
8. COSETTE
Cosette Pharmaceuticals Inc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Cosette.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | solution | Discontinued | TOPICAL | N/A | Dec 15, 1995 |
9. ENCUBE
Encube Ethicals Private Ltd has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Encube.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05%
(reference standard) | cream | Prescription | TOPICAL | AB1 | Aug 28, 2020 |
10. EPIC PHARMA LLC
Epic Pharma Llc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | lotion | Discontinued | TOPICAL | N/A | Oct 26, 2018 |
11. FOUGERA PHARMS
Fougera Pharmaceuticals Inc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Fougera Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05%
(reference standard) | gel | Prescription | TOPICAL | AB | Feb 15, 2000 |
12. FOUGERA PHARMS INC
Fougera Pharmaceuticals Inc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Fougera Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | cream | Prescription | TOPICAL | AB1 | Sep 30, 1996 |
13. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | aerosol, foam | Prescription | TOPICAL | AB2 | Sep 9, 2019 |
14. GLENMARK SPECLT
Glenmark Specialty Sa has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | cream | Prescription | TOPICAL | AB1 | May 10, 2018 |
15. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | shampoo | Discontinued | TOPICAL | N/A | Oct 27, 2017 |
16. LUPIN LTD
Lupin Ltd has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | spray | Prescription | TOPICAL | AT | Mar 26, 2018 |
17. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | ointment | Prescription | TOPICAL | AB | Dec 28, 2023 |
18. NOVAST LABS
Novast Laboratories Inc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Novast Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | aerosol, foam | Discontinued | TOPICAL | N/A | Jul 31, 2017 |
19. NOVEL LABS INC
Novel Laboratories Inc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Novel Labs Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | ointment | Prescription | TOPICAL | AB | May 4, 2018 |
20. PADAGIS ISRAEL
Padagis Israel Pharmaceuticals Ltd has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Padagis Israel.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05%
(reference standard) | aerosol, foam | Prescription | TOPICAL | AB2 | Aug 14, 2012 |
21. PADAGIS US
Padagis Us Llc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Padagis Us.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | spray | Prescription | TOPICAL | AT | Jun 16, 2011 |
22. PAI HOLDINGS PHARM
Pai Holdings Llc Dba Pharmaceutical Associates Inc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Pai Holdings Pharm.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | ointment | Discontinued | TOPICAL | N/A | Jan 23, 2019 |
23. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Prinston Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | solution | Discontinued | TOPICAL | N/A | Feb 8, 2021 |
24. QUAGEN
Quagen Pharmaceuticals Llc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Quagen.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | solution | Prescription | TOPICAL | AT | Feb 17, 2022 |
25. RISING
Rising Pharma Holdings Inc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Rising.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | cream | Prescription | TOPICAL | AB1 | Jan 11, 2019 |
26. SAPTALIS PHARMS
Saptalis Pharmaceuticals Llc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Saptalis Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | solution | Prescription | TOPICAL | AT | Oct 2, 2019 |
27. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | spray | Discontinued | TOPICAL | N/A | Apr 28, 2017 |
28. TARO
Taro Pharmaceutical Industries Ltd has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Taro.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | aerosol, foam | Prescription | TOPICAL | AB2 | Mar 14, 2024 |
29. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | cream | Discontinued | TOPICAL | N/A | Feb 16, 1994 |
30. TORRENT
Torrent Pharmaceuticals Ltd has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Torrent.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | cream | Discontinued | TOPICAL | N/A | Dec 30, 2019 |
31. WOCKHARDT BIO AG
Wockhardt Bio Ag has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Wockhardt Bio Ag.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | solution | Discontinued | TOPICAL | N/A | Nov 13, 1998 |
32. XIROMED
Xiromed Pharma Espana Sl has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Xiromed.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | cream | Prescription | TOPICAL | AB1 | Jun 15, 2018 |
33. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | lotion | Prescription | TOPICAL | AB | Sep 24, 2019 |
34. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Clobetasol Propionate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
0.05% | cream | Prescription | TOPICAL | AB1 | Oct 15, 2018 |